| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Previous issue > Previous issue



Table of Contents | October, 2005  Vol. 37  No.5 Previous Issue | Next Issue | Archive
In this issue:


Review Article
257 Epstein-Barr Virus in Human Malignancy: A Special Reference to Epstein-Barr Virus associated Gastric Carcinoma
Mee Soo Chang, Woo Ho Kim
Cancer Res Treat. 2005;37(5):257-267.   Published online October 31, 2005    DOI: https://doi.org/10.4143/crt.2005.37.5.257
                                 Cited By 11
Original Articles
268 Results of Curative Radiation Therapy with or without Chemotherapy for Stage III Unresectable Non-Small Cell Lung Cancer
Sung-Ja Ahn, Young-Chul Kim, Kyu-Sik Kim, Kyung-Ok Park, Woong-Ki Chung, Taek-Keun Nam, Byung-Sik Nah, Ju-Young Song, Mi-Sun Yoon
Cancer Res Treat. 2005;37(5):268-272.   Published online October 31, 2005    DOI: https://doi.org/10.4143/crt.2005.37.5.268
                                 Cited By 2
273 Treatment Outcomes of Three-Dimensional Conformal Radiotherapy for Stage III Non-Small Cell Lung Cancer
Seung-Gu Yeo, Moon-June Cho, Sun-Young Kim, Seung-Pyung Lim, Ki-Hwan Kim, Jun-Sang Kim
Cancer Res Treat. 2005;37(5):273-278.   Published online October 31, 2005    DOI: https://doi.org/10.4143/crt.2005.37.5.273
                                 Cited By 1
279 Oxaliplatin with Biweekly Low Dose Leucovorin and Bolus and Continuous Infusion of 5-fluorouracil (Modified FOLFOX 4) as a Salvage Therapy for Patients with Advanced Gastric Cancer
Sung-Hwan Suh, Hyuk-Chan Kwon, Ji-Hoon Jo, Young-Rak Cho, Bong-Gun Seo, Dong-Mee Lee, Sung-Hyun Kim, Jae-Seok Kim, Hyo-Jin Kim
Cancer Res Treat. 2005;37(5):279-283.   Published online October 31, 2005    DOI: https://doi.org/10.4143/crt.2005.37.5.279
                                 Cited By 8
284 Combination Chemotherapy of Oxaliplatin, 5-Fluorouracil and Low Dose Leucovorin in Patients with Advanced Colorectal Cancer
Yoon Mi Shin, Hae Suk Han, Seong Woo Lim, Byung Chul Kim, Kyung Suck Cheoi, Young Ook Eum, Seung Taek Kim, Ki Hyeong Lee
Cancer Res Treat. 2005;37(5):284-289.   Published online October 31, 2005    DOI: https://doi.org/10.4143/crt.2005.37.5.284
                                 Cited By 1
290 Comparison of WHO and RECIST Criteria for Response in Metastatic Colorectal Carcinoma
Jung-Hye Choi, Myung-Ju Ahn, Hyan-Chul Rhim, Jin-Woo Kim, Gang-Hong Lee, Young-Yeul Lee, In-Soon Kim
Cancer Res Treat. 2005;37(5):290-293.   Published online October 31, 2005    DOI: https://doi.org/10.4143/crt.2005.37.5.290
                                 Cited By 11
294 Prognostic Factors in Non-Hodgkin's Lymphoma Patients Treated by Autologous Stem Cell Transplantation: A Single Center Experience
Cheolwon Suh, Sang Hee Kim, Hyo Jung Kim, Geundoo Jang, Eun Kyung Kim, Ok Bae Ko, Shin Kim, Hee Jung Sohn, Jung Shin Lee, M. Wookun Kim, Jooryung Huh
Cancer Res Treat. 2005;37(5):294-301.   Published online October 31, 2005    DOI: https://doi.org/10.4143/crt.2005.37.5.294
                                 Cited By 1
302 Relationship between Pre-treatment Serum SCC (squamous cell carcinoma) Antigen, Cyfra 21-1 Levels, and Survival in Squamous Cell Carcinoma of the Uterine Cervix
Ki-Hong Chang, Hee-Sug Ryu, Suk-Joon Chang, Young-Ji Byun, Jung-Pil Lee
Cancer Res Treat. 2005;37(5):302-306.   Published online October 31, 2005    DOI: https://doi.org/10.4143/crt.2005.37.5.302
                              
307 Tetraarsenic Oxide-mediated Apoptosis in a Cervical Cancer Cell Line, SiHa [Retraction in]
Jeong Kim, Su-Mi Bae, Dae-Seog Lim, Sun-Young Kwak, Chang-Ki Lee, Yong-Seok Lee, IL-Ju Bae, Jin-Young Yoo, Young-Joo Lee, Chong-Kook Kim, Woong-Shick Ahn
Cancer Res Treat. 2005;37(5):307-312.   Published online October 31, 2005    DOI: https://doi.org/10.4143/crt.2005.37.5.307
  Cited By 2
313 Pattern of Apoptosis by NS398, a Selective COX-2 Inhibitor, in Hepatocellular Carcinoma Cell Lines
Mi Kyung Park, Moon Kyu Kim, Jung Chul Kim, Young Kwan Sung
Cancer Res Treat. 2005;37(5):313-317.   Published online October 31, 2005    DOI: https://doi.org/10.4143/crt.2005.37.5.313
                                 Cited By 3
Korean Cancer Association
E-Submission
EndNote Output Style
Email Alert
Cancer Research and Treatment 2017; 49(4): 915-926.
Impact factor
SCImago Journal & Country Rank
PubMed Central
MEDLINE/PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
ORCID
COPE
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association. All rights reserved.                 Developed in M2Community